Sagimet Biosciences Announces Appointment of Thierry Chauche

SAN MATEO, Calif., May 06, 2024 -- Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors designed to target dysfunctional metabolic...

Related Keywords

France , Chauche , Pays De La Loire , Ecole , Franche Comtér , United States , Paris , France General , Dave Happel , Sagimet Biosciences , Rothschild Cie , Ponts Paristech , Provention Bio , Joyce Allaire , Compensation Committee , Wharton School , Sagimet Biosciences Inc , Company Series , Exchange Commission , Nasdaq , University Of Pennsylvania , Novartis , Prior To Alexion Pharmaceuticals , Intercept Pharmaceuticals , Thierry Chauche , Chief Financial Officer , Before Provention Bio , Vice President , Strategic Financial Planning , Alexion Pharmaceuticals , Ecole Des Ponts Paristech , Black Scholes , Nasdaq Rule , Nasdaq Global Market , Private Securities Litigation Reform Act , Sci Advisors , Markets ,